medroxyprogesterone acetate 5 MG Oral Tablet
- RxCUI
- 1000141
- RxNorm name
- medroxyprogesterone acetate 5 MG Oral Tablet
- Display name
- medroxyPROGESTERone (Oral Pill)
- Full name
- medroxyprogesterone acetate 5 MG Oral Tablet
- Term type
- SCD
- Status
- Active
- Strength
- 5 mg
- Dose form
- Tab
- Route
- Oral Pill
- Updated
- 2026-10-21 07:26:41
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092010
- Active start
- 092010
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| medroxyprogesterone acetate | 5 MG / 1 EACH | medroxyprogesterone | medroxyprogesterone acetate |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Tablet | 317541 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| medroxyprogesterone | 6691 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | medroxyPROGESTERone acetate 5 MG Oral Tablet | 1 | NAMES |
| RxNorm Name | medroxyprogesterone acetate 5 MG Oral Tablet | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 5 | CODES | |
| RxCUI | 1000141 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0555-0873-02 | 0555-0873 | Medroxyprogesterone Acetate Medroxyprogesterone Acetate | Teva Pharmaceuticals USA, Inc. | ANDA040159 |
| 0555-0873-04 | 0555-0873 | Medroxyprogesterone Acetate Medroxyprogesterone Acetate | Teva Pharmaceuticals USA, Inc. | ANDA040159 |
| 50090-0491-1 | 50090-0491 | Medroxyprogesterone Acetate Medroxyprogesterone Acetate | A-S Medication Solutions | ANDA040159 |
| 59762-0058-1 | 59762-0058 | medroxyprogesterone acetate medroxyprogesterone acetate | Mylan Pharmaceuticals Inc. | NDA011839 |
| 59762-0058-2 | 59762-0058 | medroxyprogesterone acetate medroxyprogesterone acetate | Mylan Pharmaceuticals Inc. | NDA011839 |
| 63629-8826-1 | 63629-8826 | Medroxyprogesterone Acetate Medroxyprogesterone Acetate | Bryant Ranch Prepack | ANDA040159 |
| 68788-8112-3 | 68788-8112 | Medroxyprogesterone Acetate Medroxyprogesterone Acetate | Preferred Pharmaceuticals Inc. | ANDA040159 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA040159 | 0555-0873 | Medroxyprogesterone Acetate Medroxyprogesterone Acetate | ANDA | Teva Pharmaceuticals USA, Inc. |
| NDA011839 | 59762-0058 | medroxyprogesterone acetate medroxyprogesterone acetate | NDA AUTHORIZED GENERIC | Mylan Pharmaceuticals Inc. |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Provera | MEDROXYPROGESTERONE ACETATE | Pharmacia & Upjohn Company LLC | a586be28-96af-4fed-a13f-9b94fd4c7405 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 1000141 |
| medroxyprogesterone acetate | MEDROXYPROGESTERONE ACETATE | Mylan Pharmaceuticals Inc. | 2627eb11-06bf-4a45-9172-094468e3ca07 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 59762-0058-1 59762-0058-2 59762-0058 59762005802 59762005801 1000141 |
| PredniSONE | PREDNISONE | Northwind Health Company, LLC | ca39fdfb-d110-6535-e053-2995a90a550a | 2026-01-01 | Warnings, Adverse reactions | 51655070153 |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | A-S Medication Solutions | bfdf335d-1cbb-4533-9fde-99a9c71f7504 | 2025-06-12 | Boxed warning, Warnings, Adverse reactions | 50090-0491-1 50090-0491 50090049101 50090049100 1000141 |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Bryant Ranch Prepack | a88b33ff-842b-4a5b-a27e-9c2b9e85a4d7 | 2024-07-08 | Boxed warning, Warnings, Adverse reactions | 63629-8826-1 63629-8826 63629882601 1000141 |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Teva Pharmaceuticals USA, Inc. | 9eb200b0-db96-4a51-87ea-04db862978c8 | 2024-03-01 | Boxed warning, Warnings, Adverse reactions | 0555-0873-04 0555-0873-02 0555-0873 00555087304 00555087302 1000141 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a88b33ff-842b-4a5b-a27e-9c2b9e85a4d7 | medroxyPROGESTERone acetate 5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 5 MG Oral Tablet [SCD] | 2 | 103 | MedroxyPROGESTERone Acetate Tablets, USP | 20240708 |
| 2627eb11-06bf-4a45-9172-094468e3ca07 | medroxyPROGESTERone acetate 5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 5 MG Oral Tablet [SCD] | 2 | 33 | Medroxyprogesterone Acetate Tablets, USP | 20260521 |
| a586be28-96af-4fed-a13f-9b94fd4c7405 | medroxyPROGESTERone acetate 5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 5 MG Oral Tablet [SCD] | 2 | 26 | PROVERA® (medroxyprogesterone acetate tablets, USP) | 20240830 |
| 9eb200b0-db96-4a51-87ea-04db862978c8 | medroxyPROGESTERone acetate 5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 5 MG Oral Tablet [SCD] | 2 | 17 | MedroxyPROGESTERone Acetate Tablets, USP | 20240301 |
| bfdf335d-1cbb-4533-9fde-99a9c71f7504 | medroxyPROGESTERone acetate 5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 5 MG Oral Tablet [SCD] | 2 | 13 | MedroxyPROGESTERone Acetate Tablets, USP | 20250612 |
| a9e05272-aa4e-4df8-b08b-481abca3e8fd | medroxyPROGESTERone acetate 5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 5 MG Oral Tablet [SCD] | 2 | 5 | MedroxyPROGESTERone Acetate Tablets, USP | 20250805 |
| 826f674c-8ef2-400a-bf0b-877320a8cb5d | medroxyPROGESTERone acetate 5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 5 MG Oral Tablet [SCD] | 2 | 3 | Medroxyprogesterone Acetate Tablets USP | 20150319 |
| 210a9132-8837-4b8a-829c-abfac2d6e3dc | medroxyPROGESTERone acetate 5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 5 MG Oral Tablet [SCD] | 2 | 2 | Medroxyprogesterone Acetate Tablets USP | 20120928 |
| 8691e529-0681-47f4-bab8-c6873f1e1424 | medroxyPROGESTERone acetate 5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 5 MG Oral Tablet [SCD] | 2 | 1 | Medroxyprogesterone Acetate Tablets, USP | 20151202 |
| fda3368b-4ce3-4972-885d-066858831ee0 | medroxyPROGESTERone acetate 5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 5 MG Oral Tablet [SCD] | 2 | 1 | Medroxyprogesterone Acetate Tablets USP | 20140113 |
| 499051ac-ffaf-4db4-be45-a409bd54991f | medroxyPROGESTERone acetate 5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 5 MG Oral Tablet [SCD] | 2 | 1 | Medroxyprogesterone Acetate Tablets, USP | 20090813 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| a9e05272-aa4e-4df8-b08b-481abca3e8fd | MedroxyPROGESTERone Acetate Tablets, USP | Preferred Pharmaceuticals Inc. | 20261009 |
| a9e05272-aa4e-4df8-b08b-481abca3e8fd | MedroxyPROGESTERone Acetate Tablets, USP | Preferred Pharmaceuticals Inc. | 20260615 |
| 2627eb11-06bf-4a45-9172-094468e3ca07 | Medroxyprogesterone Acetate Tablets, USP | Mylan Pharmaceuticals Inc. | Pfizer Inc | Pharmacia & Upjohn Company LLC | Pfizer Italia S.r.l. | 20260521 |
| ca39fdfb-d110-6535-e053-2995a90a550a | PredniSONE Tablets, USP | Northwind Health Company, LLC | 20260101 |
| a9e05272-aa4e-4df8-b08b-481abca3e8fd | MedroxyPROGESTERone Acetate Tablets, USP | Preferred Pharmaceuticals Inc. | 20250805 |
| bfdf335d-1cbb-4533-9fde-99a9c71f7504 | MedroxyPROGESTERone Acetate Tablets, USP | A-S Medication Solutions | 20250612 |
| a88b33ff-842b-4a5b-a27e-9c2b9e85a4d7 | MedroxyPROGESTERone Acetate Tablets, USP | Bryant Ranch Prepack | 20240708 |
| 9eb200b0-db96-4a51-87ea-04db862978c8 | MedroxyPROGESTERone Acetate Tablets, USP | Teva Pharmaceuticals USA, Inc. | 20240301 |
| 20c0841f-740c-4d53-af55-938c4e5b09e5 | Medroxyprogesterone Acetate Tablets, USP | PD-Rx Pharmaceuticals, Inc. | 20220321 |
| 04d23262-b778-4815-b56f-6ca6fef826c0 | MedroxyPROGESTERone Acetate Tablets USP | Bryant Ranch Prepack | 20190807 |
| 8691e529-0681-47f4-bab8-c6873f1e1424 | Medroxyprogesterone Acetate Tablets, USP | Avera McKennan Hospital | 20151202 |
| 826f674c-8ef2-400a-bf0b-877320a8cb5d | Medroxyprogesterone Acetate Tablets USP | Blenheim Pharmacal, Inc. | 20150319 |
| fda3368b-4ce3-4972-885d-066858831ee0 | Medroxyprogesterone Acetate Tablets USP | Aidarex Pharmaceuticals LLC | 20140113 |
| 807ce876-a923-4e09-a4bb-e5f08ecb1534 | National Council for Prescription Drug Programs | 20130213 | |
| 4969452d-e408-49e9-9d21-d7cc5f4e5ce4 | National Council for Prescription Drug Programs | 20130213 | |
| 210a9132-8837-4b8a-829c-abfac2d6e3dc | Medroxyprogesterone Acetate Tablets USP | Dispensing Solutions, Inc. | PSS World Medical, Inc. | 20120928 |
| 8ebd6fbc-1c5a-4b2e-b5f8-c78274a89fb6 | National Council for Prescription Drug Programs | 20120724 | |
| a83c2bdf-9cbb-4a32-b876-44a457ca366c | National Council for Prescription Drug Programs | 20120724 | |
| 3f7e8fbd-e521-421b-9b8e-024df9e279d9 | National Council for Prescription Drug Programs | 20120724 | |
| 21d4ffed-e705-4625-b849-b55364556377 | National Council for Prescription Drug Programs | 20120724 | |
| c6eb15eb-456e-4040-bf16-be9dba9a991b | National Council for Prescription Drug Programs | 20120724 | |
| c79267cb-82b2-4548-995f-86c5347a0e32 | National Council for Prescription Drug Programs | 20120724 | |
| 213c66ae-b275-4ed8-8f25-fa730e6b5380 | National Council for Prescription Drug Programs | 20120724 | |
| 499051ac-ffaf-4db4-be45-a409bd54991f | Medroxyprogesterone Acetate Tablets, USP | Physicians Total Care, Inc. | 20090813 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | G03DA | Pregnen (4) derivatives | ATC1-4 | medroxyprogesterone | |
| ATC | L02AB | Progestogens | ATC1-4 | medroxyprogesterone | |
| ATC | G03AC | Progestogens | ATC1-4 | medroxyprogesterone | |
| FDASPL | D045167 | Progesterone Congeners | CHEM | has_chemical_structure | medroxyprogesterone |
| FDASPL | N0000175602 | Progestin | EPC | has_epc | medroxyprogesterone |
| MEDRT | D008525 | Medroxyprogesterone | CHEM | has_ingredient | medroxyprogesterone |
| MEDRT | D017258 | Medroxyprogesterone Acetate | CHEM | has_ingredient | medroxyprogesterone acetate |
| MEDRT | D000568 | Amenorrhea | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D000568 | Amenorrhea | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D002292 | Carcinoma, Renal Cell | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D002292 | Carcinoma, Renal Cell | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D002543 | Cerebral Hemorrhage | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D002543 | Cerebral Hemorrhage | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D004714 | Endometrial Hyperplasia | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D004714 | Endometrial Hyperplasia | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D016889 | Endometrial Neoplasms | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D016889 | Endometrial Neoplasms | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D006470 | Hemorrhage | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D006470 | Hemorrhage | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D007040 | Hypoventilation | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D007040 | Hypoventilation | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D009376 | Neoplasms, Hormone-Dependent | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D009376 | Neoplasms, Hormone-Dependent | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D011247 | Pregnancy | DISEASE | may_prevent | medroxyprogesterone acetate |
| MEDRT | D011247 | Pregnancy | DISEASE | may_prevent | medroxyprogesterone |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D011655 | Pulmonary Embolism | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D011655 | Pulmonary Embolism | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D013924 | Thrombophlebitis | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D013924 | Thrombophlebitis | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D014623 | Vaginal Diseases | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D014623 | Vaginal Diseases | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D020246 | Venous Thrombosis | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D020246 | Venous Thrombosis | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | N0000000185 | Progestational Hormone Receptor Agonists | MOA | has_moa | medroxyprogesterone acetate |
| MEDRT | N0000000185 | Progestational Hormone Receptor Agonists | MOA | has_moa | medroxyprogesterone |
| MEDRT | N0000008630 | Decreased Follicle Stimulating Hormone Secretion | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000008630 | Decreased Follicle Stimulating Hormone Secretion | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000008632 | Decreased Growth Hormone Secretion | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000008632 | Decreased Growth Hormone Secretion | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009051 | Gonadotropin Releasing Hormone Alteration | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000009051 | Gonadotropin Releasing Hormone Alteration | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009715 | Inhibit Ovarian Follicular Phase | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000009715 | Inhibit Ovarian Follicular Phase | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009717 | Inhibit Ovulation | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000009717 | Inhibit Ovulation | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009857 | Stimulate Breast Glandular Development | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000009857 | Stimulate Breast Glandular Development | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000000043 | Hepatic Excretion | PK | has_pk | medroxyprogesterone |
| MEDRT | N0000000043 | Hepatic Excretion | PK | has_pk | medroxyprogesterone acetate |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | medroxyprogesterone |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | medroxyprogesterone acetate |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | medroxyprogesterone |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | medroxyprogesterone acetate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 5 MG (expressed as medroxyprogesterone acetate) |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA040159 |
| CODES | SNOMEDCT | 325609008 |
| CODES | VUID | 4002355 |
| NAMES | Prescribable Synonym | medroxyPROGESTERone acetate 5 MG Oral Tablet |
| NAMES | Tallman Synonym | medroxyPROGESTERone acetate 5 MG Oral Tablet |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |